Poseida Therapeutics News

Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Lloyd Marcea Bland

Jun 19 04:22

Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schmid John P.

Jun 19 04:22

Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Collins Cynthia

Jun 19 04:20

Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corning Luke

Jun 19 04:19

Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BAUM CHARLES M

Jun 19 04:18

Poseida Therapeutics | 8-K: Current report

Jun 19 04:17

Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Amado Rafael

Jun 19 04:17

Poseida Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.97%)

Jun 8 01:33

Poseida Therapeutics | 10-Q: Quarterly report

May 15 04:20

Poseida Therapeutics | 8-K: Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024

May 15 04:10

Poseida Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis Pharma AG(0%),Novartis AG(0%)

May 9 04:06

Poseida Therapeutics | EFFECT: Others

May 6 18:13

Poseida Therapeutics | CORRESP: CORRESP

May 2 10:22

Poseida Therapeutics | 8-K: Current report

May 1 21:09

Poseida Therapeutics | ARS: Annual Report to Security Holders

Apr 26 04:18

Poseida Therapeutics | DEFA14A: Others

Apr 26 04:14

Poseida Therapeutics | DEF 14A: Definitive information statements

Apr 26 04:12

Poseida Therapeutics | 8-K: Current report

Apr 17 21:19

Poseida Therapeutics | UPLOAD: Others

Apr 12 10:16

Poseida Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 9 05:05